Cargando…

Transforming Access to Specialist Care for Inflammatory Bowel Disease: The PACE Telemedicine Program

BACKGROUND: There are significant geographic disparities in the delivery of IBD healthcare in Ontario which may ultimately impact health outcomes. Telemedicine-based health services may potentially bridge gaps in access to gastroenterologists in remote and underserved areas. METHODS: We conducted a...

Descripción completa

Detalles Bibliográficos
Autores principales: Habashi, Peter, Bouchard, Shelley, Nguyen, Geoffrey C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6785695/
https://www.ncbi.nlm.nih.gov/pubmed/31616860
http://dx.doi.org/10.1093/jcag/gwy046
_version_ 1783457943667081216
author Habashi, Peter
Bouchard, Shelley
Nguyen, Geoffrey C
author_facet Habashi, Peter
Bouchard, Shelley
Nguyen, Geoffrey C
author_sort Habashi, Peter
collection PubMed
description BACKGROUND: There are significant geographic disparities in the delivery of IBD healthcare in Ontario which may ultimately impact health outcomes. Telemedicine-based health services may potentially bridge gaps in access to gastroenterologists in remote and underserved areas. METHODS: We conducted a needs assessment for IBD specialist care in Ontario using health administrative data. As part of a separate initiative to address geographic disparities in access to care, we described the development and implementation of our Promoting Access and Care through Centres of Excellence (PACE) Telemedicine Program. Over the first 18 months, we measured wait times and potential cost savings. RESULTS: We found substantial deficiencies in specialist care early in the course of IBD and continuous IBD care in regions where the number of gastroenterologists per capita were low. The PACE Telemedicine Program enabled new IBD consultations within a median time of 17 days (interquartile range [IQR], 7–32 days) and visits for active IBD symptoms with a median time of 8.5 days (IQR, 4–14 days). Forty-five percent of new consultations and 83% of patients with active IBD symptoms were seen within the target wait time of two weeks. Telemedicine services resulted in an estimated cost savings of $47,565 among individuals who qualified for Ontario’s Northern Travel Grant. CONCLUSIONS: The implementation of telemedicine services for IBD is highly feasible and can reduce wait times to see gastroenterologists that meet nationally recommended targets and can lead to cost savings.
format Online
Article
Text
id pubmed-6785695
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-67856952019-10-15 Transforming Access to Specialist Care for Inflammatory Bowel Disease: The PACE Telemedicine Program Habashi, Peter Bouchard, Shelley Nguyen, Geoffrey C J Can Assoc Gastroenterol Original Articles BACKGROUND: There are significant geographic disparities in the delivery of IBD healthcare in Ontario which may ultimately impact health outcomes. Telemedicine-based health services may potentially bridge gaps in access to gastroenterologists in remote and underserved areas. METHODS: We conducted a needs assessment for IBD specialist care in Ontario using health administrative data. As part of a separate initiative to address geographic disparities in access to care, we described the development and implementation of our Promoting Access and Care through Centres of Excellence (PACE) Telemedicine Program. Over the first 18 months, we measured wait times and potential cost savings. RESULTS: We found substantial deficiencies in specialist care early in the course of IBD and continuous IBD care in regions where the number of gastroenterologists per capita were low. The PACE Telemedicine Program enabled new IBD consultations within a median time of 17 days (interquartile range [IQR], 7–32 days) and visits for active IBD symptoms with a median time of 8.5 days (IQR, 4–14 days). Forty-five percent of new consultations and 83% of patients with active IBD symptoms were seen within the target wait time of two weeks. Telemedicine services resulted in an estimated cost savings of $47,565 among individuals who qualified for Ontario’s Northern Travel Grant. CONCLUSIONS: The implementation of telemedicine services for IBD is highly feasible and can reduce wait times to see gastroenterologists that meet nationally recommended targets and can lead to cost savings. Oxford University Press 2019-12 2018-08-17 /pmc/articles/PMC6785695/ /pubmed/31616860 http://dx.doi.org/10.1093/jcag/gwy046 Text en © The Author(s) 2018. Published by Oxford University Press on behalf of the Canadian Association of Gastroenterology. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Original Articles
Habashi, Peter
Bouchard, Shelley
Nguyen, Geoffrey C
Transforming Access to Specialist Care for Inflammatory Bowel Disease: The PACE Telemedicine Program
title Transforming Access to Specialist Care for Inflammatory Bowel Disease: The PACE Telemedicine Program
title_full Transforming Access to Specialist Care for Inflammatory Bowel Disease: The PACE Telemedicine Program
title_fullStr Transforming Access to Specialist Care for Inflammatory Bowel Disease: The PACE Telemedicine Program
title_full_unstemmed Transforming Access to Specialist Care for Inflammatory Bowel Disease: The PACE Telemedicine Program
title_short Transforming Access to Specialist Care for Inflammatory Bowel Disease: The PACE Telemedicine Program
title_sort transforming access to specialist care for inflammatory bowel disease: the pace telemedicine program
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6785695/
https://www.ncbi.nlm.nih.gov/pubmed/31616860
http://dx.doi.org/10.1093/jcag/gwy046
work_keys_str_mv AT habashipeter transformingaccesstospecialistcareforinflammatoryboweldiseasethepacetelemedicineprogram
AT bouchardshelley transformingaccesstospecialistcareforinflammatoryboweldiseasethepacetelemedicineprogram
AT nguyengeoffreyc transformingaccesstospecialistcareforinflammatoryboweldiseasethepacetelemedicineprogram